Takeda Pharmaceutical Company (B), The Millennium Acquisition Case Solution Yasuchika Hasegawa, president of Takeda Pharmaceutical Company, dreamt to make Takeda a leading tier company in oncology by 2015. In 2008, Takeda got Millennium Pharmaceuticals, a reputable oncology company with yearly sales of $528 million in 2007 and an appealing pipeline of brand-new drugs. Hasegawa and […]